Navigation Links
2013 Cancer Diagnostics Market Analysis: Cancer Testing Industry Growing Rapidly
Date:4/18/2013

DALLAS, April 18, 2013 /PRNewswire-iReach/ -- 2013 Analysis of Cancer Diagnostic Testing Market in US, Europe (France, Germany, Italy, Spain, UK), Japan with Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies and Competitive Landscape now available in new industry research reports at ReportsnReports.com.

(Photo: http://photos.prnewswire.com/prnh/20130418/CG97149)

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease.  During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field.  Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy.  The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

ReportsnReports.com, the fastest growing market research reports library online, in collaboration with publishing partner Venture Planning Group, offers 7 newly published reports on cancer diagnostics and cancer testing industry. Here are details:

2013 Analysis of the Beta-2 Microglobulin Testing Market

This 243 pages report presents a detailed analysis of the ß-2 Microglobulin testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.

2013 Analysis of the AFP Testing Market

This 248 pages report presents a detailed analysis of the Alpha-fetoprotein testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.

2013 Analysis of the PSA Testing Market

This 249 pages report presents a detailed analysis of the PSA testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.

2013 Analysis of the Pap Smear/HPV Testing Market

This 243 pages report presents a detailed analysis of the Pap Smear/HPV testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment.

2013 Analysis of the Prostatic Acid Phosphatase Testing Market

This 242 pages report presents a detailed analysis of the PAP testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.

2013 Analysis of the Occult Blood Testing Market

This 243 pages report presents a detailed analysis of the Occult Blood testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.

2013 Analysis of the CEA Testing Market

This 250 pages report presents a detailed analysis of the CEA testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.

These reports also examine market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; review features and operating characteristics of automated analyzers; profile leading suppliers and recent market entrants developing innovative technologies and products as well as identify alternative market penetration strategies and entry barriers/risks.

Explore more reports on:

About Us:

ReportsnReports.com (http://www.reportsnreports.com/) is an online market research reports library of 250,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers.

Explore reports on multiple industries @ http://www.sandlerresearch.org/. We also have reports targeted at Chinese markets and industries @ http://www.chinamarketresearchreports.com/.

Media Contact: Priyank Tiwari ReportsnReports.com, +1 888 391 5441, sales@reportsandreports.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE ReportsnReports
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Aethlon Medical Discloses Cancer and Infectious Disease Therapy Presentation at ISEV 2013
2. Debiopharm Group to Support Ascepion in the Development of Debio 1144 for the Treatment of Chinese Cancer Patients
3. Une nouvelle immunothérapie anticancéreuse sur le point dentrer en phase dessais cliniques
4. Se prepara para entrar en ensayos clínicos una nueva inmunoterapia contra el cáncer
5. Novel Cancer Immunotherapy set to enter Clinical Trials
6. Study Published in European Radiology Further Supports the Use of Hologics Breast Tomosynthesis in Cancer Screening in Practices Using Double Reads
7. Mendelsohn To Talk Personalized Cancer Therapy at Bush Library and Museum April Issues Forum
8. Prostate Cancer Patient Receives First Treatment Using Latest Version of Vitesse Real-Time Brachytherapy Planning System from Varian Medical Systems
9. Exosome Diagnostics Presents Data Demonstrating Clinical Applications of Exosome Technology in Brain Cancer, Prostate Cancer, and Alzheimers Disease at the International Society for Extracellular Vesicles 2013 Annual Meeting
10. New Versa HD System Tops Elektas Comprehensive Array of Cancer Management Solutions at 2nd ESTRO Forum
11. Icy therapy spot treats cancer in the lung
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... -- Hill-Rom Holdings, Inc. (NYSE: HRC), will host its ... on Friday, November 3, 2017, beginning at 7:00 a.m. ... 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... and guidance for 2018, Hill-Rom executives will also highlight ... and long-range financial outlook through 2020. ...
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion to ... awards. Ranked as number one in the South Florida Business ... in Inc. 5000 yearly list, the national specialty pharmacy has ... Armando Bardisa will soon be honored by SFBJ as ... Set to receive his award in October, ...
(Date:9/25/2017)... --  Montrium , an industry leader in powerful ... Trial Master Files & Inspection Readiness Conference ( ... Services has selected eTMF Connect to ... a leading European contract research organization (CRO), will ... enable greater collaboration with sponsors, improve compliance and ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... in the greater Dallas, Miami, and Raleigh regions, is organizing an extended charity ... a rare and deadly chromosome abnormality. , After struggling since birth with several ...
(Date:10/13/2017)... WI (PRWEB) , ... October 13, 2017 , ... As ... in medicine known as “patient engagement.” The patient is doing more than filling out ... partners. , “There is an increasing emphasis in health care and research on ...
(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected ... Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the position ... the end of 2018. Upon assuming the role of President and CEO on January ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a ... utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the ... a CBD form that can be easily incorporated into liquid products, while reducing costs ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder ... of ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership ... rules. It also provides a forum to network with elder law attorneys nationwide,” said ...
Breaking Medicine News(10 mins):